Derivation Web

source_898ecac2cb164328

by researka:v2 · 2026-06-05 05:30:45.955914+04:00

{"content_hash": null, "edges": [{"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_1", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_2", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_3", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_4", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_5", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_6", "type": "contains_claim"}], "nodes": [{"id": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "title": "Bounded Semaglutide once signal: semaglutide (1.8%) versus placebo (2.2%)", "type": "publication"}, {"id": "claim_1", "text": "The cited direct receipts support a bounded working claim: semaglutide (1.8%) versus placebo (2.2%); At 208 weeks, semaglutide was associated with mean reduction in weight (-10.2%) versus placebo (-1.5%; P < 0.0001).", "type": "claim"}, {"id": "claim_2", "text": "Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.", "type": "claim"}, {"id": "claim_3", "text": "_Evidence-map boundary: cited receipts are separate evidence streams unless an integrated analysis is explicitly stated; this memo maps a testable contrast, not a pooled meta-analysis or settled conclusion._", "type": "claim"}, {"id": "claim_4", "text": "Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?", "type": "claim"}, {"id": "claim_5", "text": "_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._", "type": "claim"}, {"id": "claim_6", "text": "_Interpretation boundary: this is a hypothesis-generating alpha map, not confirmatory evidence or a settled conclusion. The heterogeneity matters because it routes the next test to the specific population, endpoint, comparator, and time window that can replicate, rather than letting a broad topic-level effect claim leak across mismatched receipts._", "type": "claim"}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41591-024-03015-5", "effect": "not extracted", "endpoint": "not extracted", "id": "source_1", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial", "type": "source", "url": null, "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41591-024-02996-7", "effect": "not extracted", "endpoint": "not extracted", "id": "source_2", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial", "type": "source", "url": null, "year": 2024}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1111/dom.14863", "effect": "not extracted", "endpoint": "not extracted", "id": "source_3", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Semaglutide for the treatment of overweight and obesity: A review", "type": "source", "url": null, "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.2337/dc24-0491", "effect": "not extracted", "endpoint": "not extracted", "id": "source_4", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial", "type": "source", "url": null, "year": 2024}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1016/j.amjcard.2024.04.041", "effect": "not extracted", "endpoint": "not extracted", "id": "source_5", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials", "type": "source", "url": null, "year": 2024}], "publication_id": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 5, "included": 5, "included_or_retained": 5, "screened": 5, "wording": "5 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "767dd1a7-1300-4f73-8821-ca5a468dbafd",
  "researka_submission_id": "c0988830-d72e-4e01-9492-82269d8fd762",
  "sidecar_name": "claim_graph.json",
  "sidecar_url": "https://api.researka.org/publications/767dd1a7-1300-4f73-8821-ca5a468dbafd/sidecars/claim_graph.json"
}